Trial Profile
UK CLL Long-term Follow-up Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Jun 2018
Price :
$35
*
At a glance
- Drugs Obinutuzumab (Primary) ; Ofatumumab (Primary) ; Alemtuzumab; Bendamustine; Cyclophosphamide; Cyclophosphamide; Fludarabine; Fludarabine; Mitoxantrone; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Acronyms UK CLL LTFU
- 13 Jun 2018 New trial record